PGxAI

PGxAI is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences.

PGxAI develops a clinical decision support platform that uses generative AI and multi-omics data to provide real-time, evidence-linked pharmacogenomic and medication-safety recommendations integrated into electronic health records, enabling personalized drug dosing and adverse event risk identification.